9/9/2025

Discover Elanco Animal Health’s latest growth, innovation, and margin strategies from the

Source: SeekingAlpha

9/8/2025

Shares of animal health company Elanco (NYSE:ELAN) jumped 2.2% in the afternoon session after the company announced its parasite protection product, Credelio Quattro, reached $100 million in net sales in less than eight months. This achievement makes the chewable tablet Elanco's fastest pet health product to achieve blockbuster status. Launched in January, Credelio Quattro protects dogs from fleas, ticks, heartworm disease, and three types of intestinal parasites. The product has rapidly gained

Source: Yahoo

9/8/2025

Credelio Quattro marked $100 million in net sales making it Elanco's fastest pet health blockbuster in history and one of the industry's fastest ever, especially with a single geographic approval Credelio Quattro joins Experior® as Elanco's second ...

Source: Yahoo

9/8/2025

If you have been following Elanco Animal Health (ELAN), the company has delivered some significant news that could shape your thinking about its future. Elanco just announced that two of its flagship pet health products, Credelio Quattro and Zenrelia, have hit major regulatory and commercial milestones. Credelio Quattro, for instance, has achieved blockbuster sales status faster than any other Elanco pet health product. Growth is expected to accelerate as expansion plans move forward. At the...

Source: Yahoo

9/8/2025

Elanco Animal Health Incorporated (NYSE: ELAN) has announced significant advancements with its two most recent pet health innovations—Credelio Quattro and Zenrelia—further demonstrating the company's commitment to helping pet owners and veterinarians around the world go beyond today's standard of treatment.

Source: Yahoo

9/3/2025

Shares of animal health company Elanco (NYSE:ELAN) fell 4.1% in the afternoon session after competitor Boehringer Ingelheim announced the U.S. launch of a new, advanced vaccine for swine.

Source: Yahoo

9/2/2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Elanco (NYSE:ELAN) and the best and worst performers in the pharmaceuticals industry.

Source: Yahoo

8/27/2025

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.32%. September E-mini S&P futures (ESU25 ) are down -0.03%, and September...

Source: Yahoo

8/27/2025

Health care stocks were mixed premarket Wednesday, as the Health Care Select Sector SPDR Fund (XLV)

Source: Yahoo

8/27/2025

Splenda®, a leading global health and wellness brand in sweeteners, has teamed up with Elanco and HATCH, as well as other partners to sponsor Nutrition Secure Indianapolis, a first-of-its-kind program addressing food insecurity and promoting proper nutrition by delivering weekly nutritious food boxes and holistic nutrition support to families across Indianapolis.

Source: Yahoo

8/26/2025

Elanco Animal Health Inc. (NYSE: ELAN) will replace Sarepta Therapeutics Inc. (NASD: SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace Brookline Bancorp Inc. (NASD: BRKL) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, September 2. S&P SmallCap 600 constituent Berkshire Hills Bancorp Inc. (XNYS: BHLB) is acquiring Brookline Bancorp in a deal expected to be completed soon, pending final closing conditions. Post merger, Berkshire Hills Bancorp will re

Source: Yahoo

8/26/2025

Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 23rd Annual Global Healthcare Conference, September 8-9, 2025. Jeff Simmons, President and CEO, and Bob VanHimbergen, Executive Vice President and CFO, will participate in a fireside chat on Tuesday, September 9 at 8:30 a.m. ET.

Source: Yahoo

8/25/2025

Source: SeekingAlpha

8/15/2025

NORTHAMPTON, MA / ACCESS Newswire / August 15, 2025 / Jeff Simmons, President and CEO of Elanco Animal Health, recently joined the Bloomberg Businessweek Daily to discuss the company's strategic framework and detail why he sees sustainable value creation ...

Source: Yahoo

8/15/2025

NYSE:ELAN 1 Year Share Price vs Fair Value Explore Elanco Animal Health's Fair Values from the Community and select...

Source: Yahoo

8/14/2025

Elanco’s second quarter results were well received by the market, reflecting both strong execution and momentum in its innovation-driven portfolio. Management credited broad-based growth across Pet Health and Farm Animal segments, with U.S. Pet Health leading the way, supported by recent product launches such as Credelio Quattro and Zenrelia. CEO Jeffrey N. Simmons noted that “growth was driven by both price and volume,” with innovation adding stability and expansion to the base business, especi

Source: Yahoo

8/12/2025

Animal health company Elanco (NYSE:ELAN) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 4.8% year on year to $1.24 billion. Guidance for next quarter’s revenue was better than expected at $1.10 billion at the midpoint, 0.9% above analysts’ estimates. Its non-GAAP profit of $0.26 per share was 29.5% above analysts’ consensus estimates.

Source: Yahoo

8/9/2025

NYSE:ELAN 1 Year Share Price vs Fair Value Explore Elanco Animal Health's Fair Values from the Community and select...

Source: Yahoo

8/8/2025

We recently published 10 Hot Stocks Making Winning Look Easy. Elanco Animal Health Inc. (NYSE:ELAN) is one of the best-performing stocks on Thursday. Elanco saw its share prices surge to a new 52-week high on Thursday as investors cheered its strong earnings performance in the second quarter of the year. During the session, Elanco Animal […]

Source: Yahoo

8/8/2025

NYSE:ELAN 1 Year Share Price vs Fair Value Explore Elanco Animal Health's Fair Values from the Community and select...

Source: Yahoo